Skip to main content
×
×
Home

Psychotropic prescribing patterns among adolescents in Northern Ireland presenting with psychotic symptoms during a 5-year period

  • G. Woods (a1), C. Shannon (a1), G. Davidson (a1), K. Hoy (a1), D. Lewis (a1), L. Tumelty (a1) and C. Mulholland (a1)...
Abstract
Objective

To report new prescriptions of psychotropic medications among adolescents presenting with new onset psychotic symptoms during a 5-year period.

Methods

The Northern Ireland Early Onset Psychosis Study is a naturalistic longitudinal observational study of patients with an early onset first psychotic episode. All patients aged <18 years presenting to specialist mental health services across Northern Ireland with new onset psychotic symptoms between 2001 and 2006 were recruited (n=113). Clinical case notes were analysed retrospectively for details of subsequent treatment with psychotropic medications.

Results

A total of 100 patients (88.5%) were prescribed some form of psychotropic medication. Over three-quarters of patients received an antipsychotic as their first medication. Risperidone (45.8%), olanzapine (24.0%) and chlorpromazine (12.5%) were the most commonly prescribed first-line antipsychotic medications. Of a total of 160 antipsychotic prescriptions, 81 (50.6%) were off-label. Prescriptions were most likely to have been deemed off-label owing to medications not being licensed in under-18s (71.6% of off-label prescriptions) but other reasons were medications being used outside licensed age ranges (23.5%) and outside licensed indications (4.9%).

Conclusions

This is the first study examining psychotropic prescribing patterns in a complete sample of all children and adolescents presenting with early onset psychotic episodes in a single geographical area. The observation of risperidone as the most commonly prescribed antipsychotic was in keeping with previous studies in child and adolescent populations. Rates of off-label prescribing were lower than previously observed although our study was the first to investigate off-label prescribing solely in children and adolescents presenting with psychotic symptoms.

Copyright
Corresponding author
*Address for correspondence: Dr G. Woods, Consultant Psychiatrist, Ards Community Hospital, Church Street, Newtownards, BT23 4AS, United Kingdom. (Email: gary.woods@setrust.hscni.net)
References
Hide All
Aparasu, RR, Bhatara, V (2005). Antipsychotic prescribing trends among youths, 1997–2002. Psychiatric Services 56, 904.
Aparasu, RR, Bhatara, V (2007). Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Current Medical Research and Opinion 23, 4956.
Baldwin, D, Kosky, N (2007). Off-label prescribing in psychiatric practice. Advances in Psychiatric Treatment 13, 414422.
Barrett, SL, Mulholland, CC, Cooper, SJ, Rushe, TM (2009). Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia. British Journal of Psychiatry 195, 6772.
Castro-Fornieles, J, Parellada, M, Soutullo, CA, Baeza, I, Gonzalez-Pinto, A, Graell, M, Paya, B, Moreno, D, de la Serna, E, Arango, C (2008). Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. Journal of Child and Adolescent Psychopharmacology 18, 327336.
Cooper, WO, Arbogast, PG, Ding, H, Hickson, GB, Fuchs, DC, Ray, WA (2006). Trends in prescribing of antipsychotic medication for US children. Ambulatory Pediatrics 6, 7983.
Cooper, WO, Hickson, GB, Fuchs, C, Arbogast, PG, Ray, WA (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics & Adolescent Medicine 158, 753759.
Doerry, UA, Kent, L (2003). Prescribing practices of community child and adolescent psychiatrists. Psychiatric Bulletin 27, 407410.
Duff, G (2003). Safety of seroxat (paroxetine) in children and adolescents under 18 years- contraindication in the treatment of depressive illness (http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019507.pdf). Accessed 22 April 2012.
Hafner, H, Maurer, K, Loffler, W, Fatkenheuer, B, An Der Heiden, W, Riecher-Rossler, A, Behrens, S, Gattaz, WF (1994). The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. The British Journal of Psychiatry. Supplement 23, 2938.
Harrison, JL, Cluxton-Keller, F, Gross, D (2012). Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care 26, 139145.
Haw, C, Stubbs, J (2010). Off-label psychotropic prescribing for young persons in medium security. Journal of Psychopharmacology 24, 14911498.
IBM Corp (2010). IBM SPSS Statistics for Macintosh, Version 19.0. Armonk. NY: IBM Corp.
National Institute for Health and Care Excellence (2002 a). Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. TA43. National Institute for Health and Care Excellence: London.
National Institute for Health and Care Excellence (2002 b). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. CG1. National Institute for Health and Care Excellence: London.
Noguera, A, Ballesta, P, Baeza, I, Arango, C, de la Serna, E, Gonzalez-Pinto, A, Parellada, M, Graell, M, Moreno, C, Otero, S, Castro-Fornieles, J (2013). Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. Journal of Clinical Psychopharmacology 33, 463471.
Olfson, M, Blanco, C, Liu, L, Moreno, C, Laje, G (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63, 679685.
Otasowie, J, Duffy, R, Freeman, J, Hollis, C (2010). Antipsychotic prescribing practice among child psychiatrists and community paediatricians. The Psychiatrist 34, 126129.
Paediatric Formulary Committee (2007). British National Formulary for Children 2007. British Medical Association, The Royal Pharmaceutical Society of Great Britain, The Royal College of Paediatrics and Child Health, and The Neonatal and Paediatric Pharmacists Group: London.
Pappadopulos, E, Jensen, PS, Schur, SB, MacIntyre, JC, Ketner, S, Van Orden, K (2002). ‘Real world’ atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophrenia Bulletin 28, 111121.
Pogge, DL, Singer, MB, Harvey, PD (2005). Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients. Journal of Child and Adolescent Psychopharmacology 15, 901912.
Rani, F, Murray, ML, Byrne, PJ, Wong, ICK (2008). Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121, 10021009.
Shireman, TI, Olson, BM, Dewan, NA (2002). Patterns of antidepressant use among children and adolescents. Psychiatric Services 53, 14441450.
Sivaprasad, L, Hassan, T, Handy, S (2006). Survey of atypical antipsychotic use by child and adolescent psychiatrists. Child and Adolescent Mental Health 11, 164167.
Stigler, KA, Potenza, MN, Posey, DJ, McDougle, CJ (2004). Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance and management. Paediatric Drugs 6, 3344.
Thomas, CR, Holzer, CE (2006). The continuing shortage of child and adolescent psychiatrists. Journal of the American Academy of Child Adolescent Psychiatry 45, 10231031.
Turkington, A, Mulholland, CC, Rushe, TM, Anderson, R, McCaul, R, Barrett, SL, Barr, RS, Cooper, SJ (2009). Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry 195, 242248.
Verdoux, H, Tournier, M, Begaud, B (2010). Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica 121, 410.
Weller, IVD, Ashby, D, Brook, R, Chambers, MGA, Chick, JD, Drummond, C, Ebmeier, KP, Gunnell, DJ, Hawking, H, Mukaetova-Ladinska, E, O’Tierney, E, Taylor, RJ, York, A Zwi, M (2004). Report of the CSM expert working group in the safety of selective serotonin reuptake inhibitor antidepressants (http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf). Accessed 22 April 2012.
Whittington, CJ, Kendall, T, Fonaghy, P, Cottrell, D, Cotgrove, A, Boddington, E (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363, 13411345.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Irish Journal of Psychological Medicine
  • ISSN: 0790-9667
  • EISSN: 2051-6967
  • URL: /core/journals/irish-journal-of-psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed